Liana Relina, PhD, Senior Researcher (Plant Production Institute named after VYa Yuriev of NAASU)
Contributing Author
in
Tools & Methods
Novel Therapeutics
Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.
Gene therapy is still an investigational technique. Viruses are commonly used as vectors to deliver a needed gene to a host (defective) cell. An ideal viral vector is supposed to be genetically stable, non-toxic, and non-immunogenic, to have a high …
Mesenchymal stem cells (MSCs) are multipotent stem/progenitor cells that are present in different tissues, including the umbilical cord, bone marrow, and fat tissue. MSCs can self-renew by dividing and differentiate …
Antisense oligonucleotides (ASOs) are short (about 12 to 25 nucleotides long), synthetic single strands of DNA or RNA that are complementary to a chosen sequence. They can alter RNA and reduce, restore, or modify protein expression. ASOs interact with proteins …
Common vaccines are synonymous with injections and grant you systemic immunity. But the injection isn’t the only way to develop immunity. And considering how most pathogens, including coronaviruses, get into our bodies, injections might not even be the best way. …